{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:32:08Z","timestamp":1783567928065,"version":"3.55.0"},"reference-count":39,"publisher":"American Psychiatric Association Publishing","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2005,4,1]]},"DOI":"10.1176\/appi.ajp.162.4.683","type":"journal-article","created":{"date-parts":[[2005,3,30]],"date-time":"2005-03-30T20:17:53Z","timestamp":1112213873000},"page":"683-690","source":"Crossref","is-referenced-by-count":182,"title":["Effect of Raloxifene on Prevention of Dementia and Cognitive Impairment in Older Women: The Multiple Outcomes of Raloxifene Evaluation (MORE) Randomized Trial"],"prefix":"10.1176","volume":"162","author":[{"given":"Kristine","family":"Yaffe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri","family":"Blackwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor W.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somnath","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Ensrud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Grady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R1624CBBFJIAC","doi-asserted-by":"crossref","unstructured":"Ott A, Breteler MM, van Harskamp F, Stijnen T, Hofman A: Incidence and risk of dementia: the Rotterdam Study. Am J Epidemiol 1998; 147:574\u2013580","DOI":"10.1093\/oxfordjournals.aje.a009489"},{"key":"R1624CBBDABEE","doi-asserted-by":"crossref","unstructured":"Hebert LE, Beckett LA, Scherr PA, Evans DA: Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Dis Assoc Disord 2001; 15:169\u2013173","DOI":"10.1097\/00002093-200110000-00002"},{"key":"R1624CBBJEJCD","doi-asserted-by":"crossref","unstructured":"Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B: Current concepts in mild cognitive impairment. Arch Neurol 2001; 58:1985\u20131992","DOI":"10.1001\/archneur.58.12.1985"},{"key":"R1624CBBBAIBE","doi-asserted-by":"crossref","unstructured":"Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, Berg L: Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001; 58:397\u2013405","DOI":"10.1001\/archneur.58.3.397"},{"key":"R1624CBBDIAJF","doi-asserted-by":"crossref","unstructured":"McEwen BS: Clinical review 108: the molecular and neuroanatomical basis for estrogen effects in the central nervous system. J Clin Endocrinol Metab 1999; 84:1790\u20131797","DOI":"10.1210\/jc.84.6.1790"},{"key":"R1624CBBIFJGF","doi-asserted-by":"crossref","unstructured":"Yaffe K, Sawaya G, Lieberburg I, Grady D: Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 1998; 279:688\u2013695","DOI":"10.1001\/jama.279.9.688"},{"key":"R1624CBBFHIIB","doi-asserted-by":"crossref","unstructured":"LeBlanc ES, Janowsky J, Chan BK, Nelson HD: Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 2001; 285:1489\u20131499","DOI":"10.1001\/jama.285.11.1489"},{"key":"R1624CBBDJGDJ","doi-asserted-by":"crossref","unstructured":"Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN III, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J (Women\u2019s Health Initiative Memory Study [WHIMS] Investigators): Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: a randomized controlled trial. JAMA 2003; 289:2651\u20132662","DOI":"10.1001\/jama.289.20.2651"},{"key":"R1624CBBFIJFF","doi-asserted-by":"crossref","unstructured":"Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH: Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women\"s Health Initiative Memory Study. JAMA 2004; 291:2947\u20132958","DOI":"10.1001\/jama.291.24.2947"},{"key":"R1624CBBBADHA","unstructured":"Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Gluer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR (Multiple Outcomes of Raloxifene Evaluation [MORE] Investigators): Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. JAMA 1999; 282:637\u2013645; correction, 1999; 282:2124"},{"key":"R1624CBBECGEE","doi-asserted-by":"crossref","unstructured":"Delmas PD, Bjarnason NH, Mitlak BH, Ravoux AC, Shah AS, Huster WJ, Draper M, Christiansen C: Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 1997; 337:1641\u20131647","DOI":"10.1056\/NEJM199712043372301"},{"key":"R1624CBBCJIGF","doi-asserted-by":"crossref","unstructured":"Wu X, Glinn MA, Ostrowski NL, Su Y, Ni B, Cole HW, Bryant HU, Paul SM: Raloxifene and estradiol benzoate both fully restore hippocampal choline acetyltransferase activity in ovariectomized rats. Brain Res 1999; 847:98\u2013104","DOI":"10.1016\/S0006-8993(99)02062-4"},{"key":"R1624CBBFFJED","doi-asserted-by":"crossref","unstructured":"Nilsen J, Mor G, Naftolin F: Raloxifene induces neurite outgrowth in estrogen receptor positive PC12 cells. Menopause 1998; 5:211\u2013216","DOI":"10.1097\/00042192-199805040-00005"},{"key":"R1624CBBBFAEG","doi-asserted-by":"crossref","unstructured":"O\u2019Neill K, Chen S, Brinton RD: Impact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer\u2019s disease. Exp Neurol 2004; 185:63\u201380","DOI":"10.1016\/j.expneurol.2003.09.005"},{"key":"R1624CBBIEFAD","doi-asserted-by":"crossref","unstructured":"Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH, Morrow M, Lippman ME, Black D, Glusman JE, Costa A, Jordan VC: The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. JAMA 1999; 281:2189\u20132197; correction, 1999; 282:2124","DOI":"10.1001\/jama.281.23.2189"},{"key":"R1624CBBEDCEG","doi-asserted-by":"crossref","unstructured":"Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C: The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD), I: clinical and neuropsychological assessment of Alzheimer\u2019s disease. Neurology 1989; 39:1159\u20131165","DOI":"10.1212\/WNL.39.9.1159"},{"key":"R1624CBBIAJCH","doi-asserted-by":"crossref","unstructured":"Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H: Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. Am J Psychiatry 1983; 140:734\u2013739","DOI":"10.1176\/ajp.140.6.734"},{"key":"R1624CBBBCIHD","doi-asserted-by":"crossref","unstructured":"Reitan RM: Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958; 8:271\u2013276","DOI":"10.2466\/pms.1958.8.3.271"},{"key":"R1624CBBDECAA","doi-asserted-by":"crossref","unstructured":"Buschke H, Fuld PA: Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 1974; 24:1019\u20131025","DOI":"10.1212\/WNL.24.11.1019"},{"key":"R1624CBBGAGED","doi-asserted-by":"crossref","unstructured":"Folstein MF, Folstein SE, McHugh PR: \u201cMini-Mental State\u201d: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189\u2013198","DOI":"10.1016\/0022-3956(75)90026-6"},{"key":"R1624CBBJBHCA","unstructured":"Yesavage JA: Geriatric Depression Scale. Psychopharmacol Bull 1988; 24:709\u2013711"},{"key":"R1624CBBFABEB","doi-asserted-by":"crossref","unstructured":"Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140:566\u2013572","DOI":"10.1192\/bjp.140.6.566"},{"key":"R1624CBBDDIIG","doi-asserted-by":"crossref","unstructured":"Hachinski VC, Lassen NA, Marshall J: Multi-infarct dementia. a cause of mental deterioration in the elderly. Lancet 1974; 2:207\u2013210","DOI":"10.1016\/S0140-6736(74)91496-2"},{"key":"R1624CBBJHIGG","doi-asserted-by":"crossref","unstructured":"Tuokko H, Frerichs RJ: Cognitive impairment with no dementia (CIND): longitudinal studies, the findings, and the issues. Clin Neuropsychol 2000; 14:504\u2013525","DOI":"10.1076\/clin.14.4.504.7200"},{"key":"R1624CBBJCAAH","doi-asserted-by":"crossref","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 1984; 34:939\u2013944","DOI":"10.1212\/WNL.34.7.939"},{"key":"R1624CBBBHCDI","doi-asserted-by":"crossref","unstructured":"Chui HC, Mack W, Jackson JE, Mungas D, Reed BR, Tinklenberg J, Chang FL, Skinner K, Tasaki C, Jagust WJ: Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability. Arch Neurol 2000; 57:191\u2013196","DOI":"10.1001\/archneur.57.2.191"},{"key":"R1624CBBFIIGI","doi-asserted-by":"crossref","unstructured":"Black LJ, Sato M, Rowley ER, Magee DE, Bekele A, Williams DC, Cullinan GJ, Bendele R, Kauffman RF, Bensch WR, Frolik CA, Termine JD, Bryant HU: Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. J Clin Invest 1994; 93:63\u201369","DOI":"10.1172\/JCI116985"},{"key":"R1624CBBCFJHJ","doi-asserted-by":"crossref","unstructured":"Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R: Effect of oestrogen during menopause on risk and age at onset of Alzheimer\u2019s disease. Lancet 1996; 348:429\u2013432","DOI":"10.1016\/S0140-6736(96)03356-9"},{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A, Bacal C, Lingle DD, Metter E: A prospective study of estrogen replacement therapy and the risk of developing Alzheimer\u2019s disease: the Baltimore Longitudinal Study of Aging. Neurology 1997; 48:1517\u20131521; correction, 1998; 51:654","DOI":"10.1212\/WNL.48.6.1517"},{"key":"atypb2","doi-asserted-by":"crossref","unstructured":"Yaffe K, Haan M, Byers A, Tangen C, Kuller L: Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction. Neurology 2000; 54:1949\u20131954","DOI":"10.1212\/WNL.54.10.1949"},{"key":"R1624CBBBDDDG","doi-asserted-by":"crossref","unstructured":"Henderson VW, Paganini-Hill A, Emanuel CK, Dunn ME, Buckwalter JG: Estrogen replacement therapy in older women. comparisons between Alzheimer\u2019s disease cases and nondemented control subjects. Arch Neurol 1994; 51:896\u2013900","DOI":"10.1001\/archneur.1994.00540210068014"},{"key":"R1624CBBIGGFI","doi-asserted-by":"crossref","unstructured":"Barkhem T, Carlsson B, Nilsson Y, Enmark E, Gustafsson J, Nilsson S: Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists\/antagonists. Mol Pharmacol 1998; 54:105\u2013112","DOI":"10.1124\/mol.54.1.105"},{"key":"R1624CBBGDFCB","doi-asserted-by":"crossref","unstructured":"Cyr M, Landry M, Di Paolo T: Modulation by estrogen-receptor directed drugs of 5-hydroxytryptamine-2A receptors in rat brain. Neuropsychopharmacology 2000; 23:69\u201378","DOI":"10.1016\/S0893-133X(00)00085-3"},{"key":"R1624CBBFFHIF","doi-asserted-by":"crossref","unstructured":"Barrett-Connor E, Grady D, Sashegyi A, Anderson PW, Cox DA, Hoszowski K, Rautaharju P, Harper KD (Multiple Outcomes of Raloxifene Evaluation [MORE] Investigators): Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE randomized trial. JAMA 2002; 287:847\u2013857","DOI":"10.1001\/jama.287.7.847"},{"key":"R1624CBBEGGFC","doi-asserted-by":"crossref","unstructured":"Yaffe K, Krueger K, Sarkar S, Grady D, Barrett-Connor E, Cox DA, Nickelsen T (Multiple Outcomes of Raloxifene Evaluation [MORE] Investigators): Cognitive function in postmenopausal women treated with raloxifene. N Engl J Med 2001; 344:1207\u20131213","DOI":"10.1056\/NEJM200104193441604"},{"key":"R1624CBBCEDHB","doi-asserted-by":"crossref","unstructured":"Chen P, Ratcliff G, Belle SH, Cauley JA, DeKosky ST, Ganguli M: Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study. Arch Gen Psychiatry 2001; 58:853\u2013858","DOI":"10.1001\/archpsyc.58.9.853"},{"key":"R1624CBBJJFGA","doi-asserted-by":"crossref","unstructured":"Launer LJ, Andersen K, Dewey ME, Letenneur L, Ott A, Amaducci LA, Brayne C, Copeland JR, Dartigues JF, Kragh-Sorensen P, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A (EURODEM Incidence Research Group and Work Groups): Rates and risk factors for dementia and Alzheimer\u2019s disease: results from EURODEM pooled analyses. Neurology 1999; 52:78\u201384","DOI":"10.1212\/WNL.52.1.78"},{"key":"R1624CBBIFAIA","unstructured":"Berg L: Clinical Dementia Rating (CDR). Psychopharmacol Bull 1988; 24:637\u2013639"},{"key":"R1624CBBJEIEG","doi-asserted-by":"crossref","unstructured":"Gussekloo J, Westendorp RG, Remarque EJ, Lagaay AM, Heeren TJ, Knook DL: Impact of mild cognitive impairment on survival in very elderly people: cohort study. BMJ 1997; 315:1053\u20131054","DOI":"10.1136\/bmj.315.7115.1053"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.162.4.683","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T15:35:45Z","timestamp":1722180945000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.162.4.683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,1]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4,1]]}},"alternative-id":["10.1176\/appi.ajp.162.4.683"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.162.4.683","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,1]]}}}